ET
AZN icon

Equitable Trust’s AstraZeneca AZN Stock Holding History

Equitable Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,455
Closed -$3.21M – 464
2025
Q4 		$3.21M Sell
17,455
-98
-0.6% -$17.2K 0.14% 121
2025
Q3 		$2.69M Sell
17,553
-402
-2% -$60.8K 0.12% 134
2025
Q2 		$2.51M Sell
17,955
-9,745
-35% -$1.37M 0.13% 138
2025
Q1 		$4.07M Sell
27,700
-322
-1% -$46.6K 0.23% 88
2024
Q4 		$3.67M Sell
28,022
-471
-2% -$65.9K 0.2% 99
2024
Q3 		$4.44M Sell
28,493
-475
-2% -$76.7K 0.28% 75
2024
Q2 		$4.52M Buy
28,968
+6,820
+31% +$1.03M 0.31% 74
2024
Q1 		$3M Buy
22,148
+174
+0.8% +$23K 0.21% 98
2023
Q4 		$2.96M Sell
21,974
-1,357
-6% -$176K 0.22% 89
2023
Q3 		$3.16M Sell
23,331
-474
-2% -$64.7K 0.26% 74
2023
Q2 		$3.41M Sell
23,805
-242
-1% -$35.6K 0.26% 70
2023
Q1 		$3.34M Sell
24,047
-3,115
-11% -$419K 0.26% 72
2022
Q4 		$3.68M Sell
27,162
-4,261
-14% -$534K 0.29% 72
2022
Q3 		$3.45M Buy
31,423
+29,273
+1,362% +$3.71M 0.29% 76
2022
Q2 		$284K Hold
2,150
– – 0.02% 329
2022
Q1 		$285K Hold
2,150
– – 0.02% 332
2021
Q4 		$250K Hold
2,150
– – 0.02% 339
2021
Q3 		$258K Hold
2,150
– – 0.02% 324
2021
Q2 		$258K Hold
2,150
– – 0.02% 325
2021
Q1 		$214K Buy
+2,150
New +$216K 0.02% 336

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Equitable Trust's AZN Position: Q1 2026 in Review

Equitable Trust sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 17,455 shares — an estimated $3.21M sold.

Equitable Trust first reported a position in AZN in Q1 2021 and held it in 20 quarters. The position peaked at $4.52M in Q2 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Equitable Trust reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Equitable Trust sold 17,455 AstraZeneca shares in Q1 2026, an estimated $3.21M.
  • Equitable Trust first reported a position in AstraZeneca in Q1 2021 and held it in 20 quarters.
  • Equitable Trust's AstraZeneca position peaked at $4.52M in Q2 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Equitable Trust's 13F filing for Q1 2026, filed 30 Apr 2026.